Navigation Links
Secretary Reinforces VA's Commitment to Research Safety and Veteran Focus
Date:7/9/2008

Research Has Set National Safety Standards, Benefits All Americans

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- In a congressional hearing Secretary of Veterans Affairs James B. Peake, M.D., discussed the safety and importance of the research programs operated by the Department of Veterans Affairs (VA) as well as an absolute commitment to its patients, while expressing regret that even a single veteran would feel improperly treated or misused.

"VA has an outstanding research program, and has been innovative in its protection of human research subjects," Peake said before the House Committee on Veterans Affairs. "I am determined that VA will remain a leader in the protection of human research subjects and in veteran-centric research."

Peake pointed out VA researchers have played key roles in the development of breakthrough medical advancement such as the cardiac pacemaker, the CT scanner and improvements to artificial limbs. The first liver transplant was performed by a VA researcher. The Department's researchers have also conducted important trials on medication for tuberculosis, schizophrenia, high blood pressure, shingles and many other diseases that affect not only veterans but all Americans.

The VA secretary's remarks came in the wake of published reports in the Washington Times about a VA research program on smoking cessation involving veterans with post-traumatic stress disorder (PTSD). Peake emphasized the research project was not a drug study, but an examination of the most effective site of care to treat heavy smokers who have PTSD, using medications approved by the Food and Drug Administration (FDA).

"Veterans with PTSD are more likely to be heavy smokers and are only half as likely to quit as are smokers without PTSD in the general population and smoking kills," Peake said.

None of the medications used in this study are investigational or experimental, all are FDA approved, and the drug that made headlines
'/>"/>

SOURCE U.S. Department of Veterans Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Health Secretary Reminds Kids to Stop Germs - Wash Hands
2. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
3. GeoVax Secures $10 Million Financing Commitment
4. On Second Anniversary, Compendia Bioscience Announces Significant Revenue Growth, Completion of Product Milestone and Expansion of Pharma Customer Commitments
5. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
6. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
7. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
8. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
9. Small Business Innovation Research Program Awards Grant to Biomoda
10. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
11. New Research Just Released: Women Can Now Safely Postpone Motherhood Until Time Is Right

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... AMPAC Fine Chemicals LLC (AFC), a ...: APFC ) announced today that it received the Env... at the Annual Statewide Environmental Summit, spo...ogy Association (CMTA), the Industrial Environment...ncil of California (CICC) held in San Diego. This...
(Date:11/25/2009)...ire/ -- Reportlinker.com announces that a new mark...,, United States Dental Devices Market Analysi...inker.com/p0158733/United-States-Dental-Devices-Ma...ited States Dental Devices Market Analysis and For...s an essential source for in-depth information and...
(Date:11/25/2009)... Swissray International, Inc. a le... ddR ) systems, announced today that its operation...ith a long term view towards growing Swissray,s me...assets and intellectual property, as well as contr...growth Swissray is now poised to move to the next ...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 62104 1Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 62104 2Local Dentist Teaches Other Dentists How to Save the Lives of Their Patients 62104 3Intriguing Scientific Results from World 26apos 3Bs Largest Intention Healing Project 3A DreamHealer 62101 1Intriguing Scientific Results from World 26apos 3Bs Largest Intention Healing Project 3A DreamHealer 62101 2New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 1New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 2New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 62098 3
...dded to hormone therapy, following surgery, signif...eath by 36% beyond clinical benefits ac... may allow clinicians to improve standard of care ...ensitive, early-stage breast ...om a large clinical program exploring the, direc...
... updated results from Phase III clinical trial --,... Takeda,Oncology Company, today announced the pres...lti-center, randomized Phase III clinical trial, c...stine, adriamycin and,dexamethasone (VAD). Results...ercent in the VcD arm as induction therapy and 35 ...
Other Medicine Technology:Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6
(Date:11/27/2009)... Biotech firm Replikins Ltd...the H1N1 virus genomic data. It shows that the le...3.7 (s.d. 4.5) during the virus,s current outbreak...els this week of 2.0 (s.d. 0.1). The H1N1 infectiv... Boston (PRWEB) November 27, 2009 -...
(Date:11/27/2009)..., , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswi...daq: SHMR ) ( "Shamir" ), a leading provider of i...c lens market, announced today that its board of d...n aggregate amount of US$ 10 million (approximatel... representative rate of exchange), or approximatel...
(Date:11/27/2009)... Voyant Health™ annou...higan) has licensed its TraumaCad Enterprise ortho... workflow solution. , (PR...ounced today that Spectrum Health (Grand Rapids, M...hopedic templating solution and its TraumaCad Exte...
(Date:11/26/2009)..., , PRINCETON, N.J., Nov. 27 /PRNewswire/ ...ll almost double over the next 25 years and annual...it $336 billion, up from $113 billion today, accor... Diabetes Care . The National Changing Diabetes... commissioned the analysis by a team from the Univ...
(Date:11/26/2009)... No more letters from the N...personalized text messages from Santa , ...ort to increase operational efficiencies at the No...to help keep children all over the globe informed ...lves in Santa’s research department have ide...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...lp improve patient safety by reducing medication e...responsible for as many as 7,000 deaths. These err...s with similar names, poor handwriting by doctors ...death due to medical mistakes. The proposed new ru...
...nal Alcoholism: Clinical and Experimental Research...of smell. Researchers from the University Clinics ...holics and 30 healthy people who were matched for ...jects were tested for odour threshold (sensitivity...
...ammatory condition of the bladder wall. It typical...lso affect men. Investigators are testing the bact...lier studies was found to be effective in treating...hat 60 percent of patients responded well compared...
...in a recent seminar organised by Guru Gobind Singh...putation', spoke about the comapny's plan of foray...ir products would create stiff competition for the... details are available in their corporate// websit...
... his colleagues are enthused by their finding of a...rying into human cells. This blocker, in its initi...nsmission of HIV between monkeys. The new study ha... form to the vagina or rectum could// save the liv...
...be a potential cure against the common cold. The b...s who have studied changes in immune cells' respon...their study of 12 healthy subjects who took one gr... //the response to vitamin C took place within fiv...
Other Medicine News:
Fluid Control 2203
...roscopy. Ease of use and superior performance are ...stem unique. , ,The 10k Fluid System, when used fo... while providing instantaneous flow and overpressu...paroscopy, provides instantaneous fluid flow or su...
Digital Video Manager
...er gives you an entirely new way to visualize, edi... the perfect tool for turning real-life surgery in...use and footswitch, you can record only the parts ...wing video tapes. With your finished DVD, you can ...
Medicine Products: